IMMUCELL CORP (ICCC) Stock Cash Flow
NASDAQ:ICCC - Nasdaq - US4525253062 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -271.70K | -2.16M | -5.77M | -2.49M | -80.00K | |||
| Depreciation Amortization | 2.70M | 2.69M | 2.72M | 2.49M | 2.46M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | 0.00 | |||
| Change In Working Capital | -1.12M | -406.50K | -2.11M | -1.83M | -1.62M | |||
| Interest Paid | 510.30K | 528.90K | 445.00K | 340.00K | 310.00K | |||
| Taxes Paid | N/A | 7.30K | 6.50K | 0.00 | 10.00K | |||
| Other non cash items | 209.90K | 233.90K | 495.30K | 300.00K | 190.00K | |||
| OPERATING CASH FLOW | 1.51M | 357.90K | -4.67M | -1.54M | 950.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -724.40K | -465.70K | -1.89M | -3.98M | -2.61M | |||
| Other Investing Activity | N/A | 4.50K | 2.50K | 10.00K | 1.01M | |||
| INVESTING CASH FLOW | -719.90K | -461.20K | -1.89M | -3.96M | -1.60M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -1.49M | -1.47M | 1.81M | 1.10M | -370.00K | |||
| Stock Issued/Repurchased | N/A | 4.65M | 18.80K | 30.00K | 4.24M | |||
| Other Financing Activity | -334.90K | -296.90K | -81.50K | -20.00K | 0.00 | |||
| FINANCING CASH FLOW | 2.85M | 2.88M | 1.75M | 1.11M | 3.88M | |||
| CHANGE IN CASH | 3.64M | 2.78M | -4.81M | -4.39M | 3.23M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 1.51M | 357.90K | -4.67M | -1.54M | 950.00K | |||
| Capital Expenditure | -724.40K | -465.70K | -1.89M | -3.98M | -2.61M | |||
| FREE CASH FLOW | 788.90K | -107.80K | -6.57M | -5.52M | -1.66M | |||
All data in USD